Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-let-7a-3p ABI3BP 0.5 0.04111 -3.78 0 miRNATAP -0.82 0.00015 NA
2 hsa-let-7b-3p ABI3BP 0.22 0.29604 -3.78 0 miRNATAP -0.95 0.00024 NA
3 hsa-miR-107 ABI3BP 0.9 5.0E-5 -3.78 0 miRanda -1.37 0 NA
4 hsa-miR-181a-5p ABI3BP 1.39 0 -3.78 0 miRNATAP -0.65 0.00361 NA
5 hsa-miR-181b-5p ABI3BP 1.64 0 -3.78 0 miRNATAP -0.66 0.00019 NA
6 hsa-miR-32-3p ABI3BP 0.58 0.11837 -3.78 0 mirMAP -0.71 1.0E-5 NA
7 hsa-miR-320a ABI3BP 0.59 0.0119 -3.78 0 miRanda -0.78 0.00061 NA
8 hsa-miR-320b ABI3BP 1.11 0.0005 -3.78 0 miRanda -0.86 0 NA
9 hsa-miR-320c ABI3BP 0.46 0.24061 -3.78 0 miRanda -0.53 0.00082 NA
10 hsa-miR-330-3p ABI3BP 0.8 0.00747 -3.78 0 PITA -0.74 3.0E-5 NA
11 hsa-miR-3662 ABI3BP 1.83 0.0054 -3.78 0 mirMAP; miRNATAP -0.44 2.0E-5 NA
12 hsa-miR-421 ABI3BP 1.81 0 -3.78 0 miRanda -0.8 0 NA
13 hsa-miR-455-5p ABI3BP 1.2 7.0E-5 -3.78 0 miRanda -0.99 0 NA
14 hsa-miR-505-5p ABI3BP 0.41 0.18433 -3.78 0 miRNATAP -0.52 0.00318 NA
15 hsa-miR-576-5p ABI3BP 0.63 0.04171 -3.78 0 PITA -0.97 0 NA
16 hsa-miR-590-3p ABI3BP 1.12 0.00016 -3.78 0 miRanda -0.97 0 NA
17 hsa-miR-590-5p ABI3BP 1.04 0.00027 -3.78 0 miRanda -1.39 0 NA
18 hsa-miR-92a-3p ABI3BP 1.22 1.0E-5 -3.78 0 miRNATAP -1.43 0 NA
19 hsa-miR-92b-3p ABI3BP 1.34 0 -3.78 0 miRNATAP -1.01 0 NA
20 hsa-miR-484 ACTA2 0.71 0.00234 -1.82 6.0E-5 miRNAWalker2 validate -0.74 0 NA
21 hsa-miR-139-5p ADAM12 -1.83 0 3.79 0 miRanda -0.94 0 NA
22 hsa-miR-26a-5p ADAM12 -0.38 0.04425 3.79 0 mirMAP; miRNATAP -0.86 0.00028 NA
23 hsa-miR-26b-5p ADAM12 -0.3 0.16008 3.79 0 mirMAP; miRNATAP -0.57 0.0067 NA
24 hsa-miR-29a-3p ADAM12 -0.11 0.61501 3.79 0 miRNATAP -0.9 1.0E-5 25886595 ADAM12 L is a direct target of the miR 29 and miR 200 families in breast cancer
25 hsa-miR-29b-3p ADAM12 -0.23 0.36746 3.79 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.62 0.00039 25886595 ADAM12 L is a direct target of the miR 29 and miR 200 families in breast cancer
26 hsa-miR-29c-3p ADAM12 -1.62 0 3.79 0 miRNATAP -0.76 0 NA
27 hsa-miR-338-3p ADAM12 -0.96 0.01915 3.79 0 miRanda -0.66 0 NA
28 hsa-miR-1271-5p ANPEP 1.16 0.00208 2.6 0.00055 mirMAP -0.44 0.00234 NA
29 hsa-miR-24-3p ANPEP 1.09 0 2.6 0.00055 miRNAWalker2 validate -0.69 0.0051 NA
30 hsa-miR-129-5p AREG -2.57 0 0.46 0.44521 miRanda -0.38 0 NA
31 hsa-miR-107 BASP1 0.9 5.0E-5 0.83 0.11881 miRanda -0.73 2.0E-5 NA
32 hsa-miR-200b-3p BASP1 0.97 0.0595 0.83 0.11881 TargetScan -0.4 0 NA
33 hsa-miR-200c-3p BASP1 1.28 0.0037 0.83 0.11881 miRNATAP -0.29 0.00068 NA
34 hsa-miR-33a-3p BASP1 0.35 0.32171 0.83 0.11881 miRNATAP -0.31 0.00765 NA
35 hsa-miR-429 BASP1 1.4 0.009 0.83 0.11881 PITA; miRanda; miRNATAP -0.34 0 NA
36 hsa-miR-532-3p BASP1 0.55 0.09755 0.83 0.11881 PITA -0.62 0 NA
37 hsa-miR-7-5p BASP1 1.64 0.01244 0.83 0.11881 miRNATAP -0.33 0 NA
38 hsa-miR-192-3p BDNF 0.36 0.74117 0.74 0.18381 MirTarget; miRNATAP -0.11 0.00424 NA
39 hsa-miR-29b-2-5p BDNF -1.7 0 0.74 0.18381 mirMAP -0.38 0.00762 NA
40 hsa-miR-338-5p BDNF -1.2 0.01003 0.74 0.18381 miRNATAP -0.3 0.00033 NA
41 hsa-miR-30b-3p BGN -0.27 0.40085 2.04 0 mirMAP -0.53 0 NA
42 hsa-miR-486-5p BGN -0.63 0.15527 2.04 0 miRanda -0.25 0.00053 NA
43 hsa-miR-139-3p BMP1 -1.08 0.00142 1.36 0 miRNATAP -0.29 0 NA
44 hsa-miR-139-5p BMP1 -1.83 0 1.36 0 miRanda -0.34 0 NA
45 hsa-miR-29a-3p BMP1 -0.11 0.61501 1.36 0 miRNATAP -0.24 0.00957 NA
46 hsa-miR-29b-3p BMP1 -0.23 0.36746 1.36 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.35 1.0E-5 NA
47 hsa-miR-29c-3p BMP1 -1.62 0 1.36 0 miRNATAP -0.33 0 NA
48 hsa-miR-30b-3p BMP1 -0.27 0.40085 1.36 0 miRNATAP -0.26 7.0E-5 NA
49 hsa-miR-335-5p BMP1 1.6 6.0E-5 1.36 0 miRNAWalker2 validate -0.2 6.0E-5 NA
50 hsa-miR-362-5p BMP1 -0.35 0.35491 1.36 0 mirMAP -0.31 0 NA
51 hsa-miR-429 BMP1 1.4 0.009 1.36 0 miRNATAP -0.11 0.00299 NA
52 hsa-miR-141-3p CADM1 1.46 0.00116 -1.21 0.02357 MirTarget; TargetScan -0.23 0.00574 NA
53 hsa-miR-27a-3p CADM1 1.3 0 -1.21 0.02357 MirTarget; miRNATAP -0.45 0.00473 NA
54 hsa-miR-31-3p CADM1 0.47 0.50687 -1.21 0.02357 MirTarget; miRNATAP -0.15 0.00568 NA
55 hsa-let-7g-5p CALD1 0.33 0.24114 -1.33 0.00086 miRNATAP -0.3 0.00385 NA
56 hsa-miR-106a-5p CALD1 -0.17 0.64287 -1.33 0.00086 miRNATAP -0.24 0.00169 NA
57 hsa-miR-106b-5p CALD1 1.71 0 -1.33 0.00086 miRNATAP -0.67 0 NA
58 hsa-miR-107 CALD1 0.9 5.0E-5 -1.33 0.00086 miRanda -0.87 0 NA
59 hsa-miR-10b-3p CALD1 0.77 0.00766 -1.33 0.00086 miRNATAP -0.31 0.00148 NA
60 hsa-miR-126-5p CALD1 0.42 0.07532 -1.33 0.00086 mirMAP -0.59 0 NA
61 hsa-miR-142-3p CALD1 1.32 0.00015 -1.33 0.00086 miRanda -0.34 2.0E-5 NA
62 hsa-miR-142-5p CALD1 1.56 1.0E-5 -1.33 0.00086 PITA; mirMAP -0.37 0 NA
63 hsa-miR-15a-5p CALD1 1.04 0 -1.33 0.00086 miRNAWalker2 validate -0.71 0 NA
64 hsa-miR-16-2-3p CALD1 1.8 0 -1.33 0.00086 mirMAP -0.67 0 NA
65 hsa-miR-17-5p CALD1 1.66 0 -1.33 0.00086 TargetScan; miRNATAP -0.53 0 NA
66 hsa-miR-182-5p CALD1 0.89 0.03106 -1.33 0.00086 MirTarget -0.32 0 NA
67 hsa-miR-196a-5p CALD1 6.59 0 -1.33 0.00086 MirTarget -0.25 0 NA
68 hsa-miR-196b-5p CALD1 5.59 0 -1.33 0.00086 MirTarget -0.3 0 NA
69 hsa-miR-197-3p CALD1 0.89 0.0002 -1.33 0.00086 MirTarget -0.64 0 NA
70 hsa-miR-20a-5p CALD1 1.45 0 -1.33 0.00086 miRNATAP -0.54 0 NA
71 hsa-miR-23b-5p CALD1 0.61 0.04865 -1.33 0.00086 miRNATAP -0.39 4.0E-5 NA
72 hsa-miR-3065-5p CALD1 -0.24 0.63312 -1.33 0.00086 mirMAP -0.24 3.0E-5 NA
73 hsa-miR-32-3p CALD1 0.58 0.11837 -1.33 0.00086 MirTarget -0.55 0 NA
74 hsa-miR-320a CALD1 0.59 0.0119 -1.33 0.00086 PITA; miRanda; miRNATAP -0.42 0.00062 NA
75 hsa-miR-320b CALD1 1.11 0.0005 -1.33 0.00086 PITA; miRanda; miRNATAP -0.45 0 NA
76 hsa-miR-320c CALD1 0.46 0.24061 -1.33 0.00086 PITA; miRanda; miRNATAP -0.37 1.0E-5 NA
77 hsa-miR-338-3p CALD1 -0.96 0.01915 -1.33 0.00086 miRanda -0.24 0.00042 NA
78 hsa-miR-338-5p CALD1 -1.2 0.01003 -1.33 0.00086 PITA; miRNATAP -0.19 0.00172 NA
79 hsa-miR-34a-5p CALD1 0.79 0.00024 -1.33 0.00086 miRNAWalker2 validate -0.6 1.0E-5 NA
80 hsa-miR-361-5p CALD1 0.41 0.01813 -1.33 0.00086 miRanda; miRNATAP -0.51 0.00262 NA
81 hsa-miR-3682-3p CALD1 1.97 0 -1.33 0.00086 mirMAP -0.46 0 NA
82 hsa-miR-421 CALD1 1.81 0 -1.33 0.00086 miRanda -0.24 0.00324 NA
83 hsa-miR-429 CALD1 1.4 0.009 -1.33 0.00086 miRanda -0.46 0 NA
84 hsa-miR-484 CALD1 0.71 0.00234 -1.33 0.00086 PITA -0.46 0.00016 NA
85 hsa-miR-501-3p CALD1 0.73 0.02704 -1.33 0.00086 TargetScan; miRNATAP -0.49 0 NA
86 hsa-miR-590-3p CALD1 1.12 0.00016 -1.33 0.00086 miRanda; mirMAP -0.56 0 NA
87 hsa-miR-590-5p CALD1 1.04 0.00027 -1.33 0.00086 miRanda -0.61 0 NA
88 hsa-miR-93-5p CALD1 1.75 0 -1.33 0.00086 miRNATAP -0.46 0 NA
89 hsa-miR-107 CALU 0.9 5.0E-5 0.28 0.17576 MirTarget; PITA; miRanda -0.17 0.00788 NA
90 hsa-miR-126-5p CALU 0.42 0.07532 0.28 0.17576 MirTarget -0.18 0.00439 NA
91 hsa-miR-141-3p CALU 1.46 0.00116 0.28 0.17576 TargetScan -0.13 2.0E-5 NA
92 hsa-miR-150-5p CALU 0.15 0.75372 0.28 0.17576 MirTarget -0.17 0 NA
93 hsa-miR-16-5p CALU 1.01 1.0E-5 0.28 0.17576 miRNAWalker2 validate; MirTarget -0.18 0.00566 NA
94 hsa-miR-200b-3p CALU 0.97 0.0595 0.28 0.17576 MirTarget; TargetScan -0.13 1.0E-5 NA
95 hsa-miR-200c-3p CALU 1.28 0.0037 0.28 0.17576 MirTarget -0.16 0 NA
96 hsa-miR-29c-3p CALU -1.62 0 0.28 0.17576 MirTarget -0.22 0 NA
97 hsa-miR-30b-5p CALU -0.43 0.05936 0.28 0.17576 MirTarget -0.27 2.0E-5 NA
98 hsa-miR-30d-3p CALU -0.55 0.04337 0.28 0.17576 MirTarget -0.18 0.00072 NA
99 hsa-miR-30d-5p CALU -0.55 0.01401 0.28 0.17576 MirTarget -0.29 1.0E-5 NA
100 hsa-miR-33a-3p CALU 0.35 0.32171 0.28 0.17576 mirMAP -0.15 0.0007 NA
101 hsa-miR-429 CALU 1.4 0.009 0.28 0.17576 MirTarget; PITA; miRanda -0.12 1.0E-5 NA
102 hsa-miR-107 CAP2 0.9 5.0E-5 -0.18 0.64669 miRanda -0.49 0.0001 NA
103 hsa-miR-320b CAP2 1.11 0.0005 -0.18 0.64669 miRanda -0.26 0.003 NA
104 hsa-miR-335-3p CAP2 2.52 0 -0.18 0.64669 mirMAP -0.21 0.00135 NA
105 hsa-miR-429 CAP2 1.4 0.009 -0.18 0.64669 miRanda -0.38 0 NA
106 hsa-miR-582-5p CAP2 -0.45 0.13462 -0.18 0.64669 PITA; miRNATAP -0.35 0.00025 NA
107 hsa-miR-590-3p CAP2 1.12 0.00016 -0.18 0.64669 PITA; miRanda; mirMAP -0.36 0.00014 NA
108 hsa-miR-628-5p CAP2 -0.54 0.03779 -0.18 0.64669 miRNATAP -0.34 0.00198 NA
109 hsa-miR-139-5p CAPG -1.83 0 1.21 1.0E-5 miRanda -0.17 0.00857 NA
110 hsa-miR-10a-3p CD44 0.22 0.56058 1.31 0.00056 mirMAP -0.36 0 NA
111 hsa-miR-148a-5p CD44 -0.69 0.0793 1.31 0.00056 mirMAP -0.34 0 23861222 In MHCC97H and MHCC97L cells over-expression of miR-148a blocked the EMT process attenuated the expression of CD90 and CD44 biomarkers for liver cancer stem cells and inhibited their migratory capacity
112 hsa-miR-30a-3p CD44 -1.73 0 1.31 0.00056 mirMAP -0.25 0.00146 NA
113 hsa-miR-30a-5p CD44 -1.72 0 1.31 0.00056 miRNAWalker2 validate -0.33 3.0E-5 NA
114 hsa-miR-30c-2-3p CD44 -1.14 0.00085 1.31 0.00056 MirTarget -0.24 0.00263 NA
115 hsa-miR-30e-3p CD44 -0.91 1.0E-5 1.31 0.00056 mirMAP -0.43 0.00129 NA
116 hsa-miR-326 CD44 -0.43 0.26299 1.31 0.00056 miRanda -0.38 0 NA
117 hsa-miR-532-3p CD44 0.55 0.09755 1.31 0.00056 miRNATAP -0.44 0 NA
118 hsa-miR-577 CD44 0.91 0.22561 1.31 0.00056 MirTarget; PITA; miRNATAP -0.23 0 NA
119 hsa-let-7d-5p CD59 0.98 0 -0.92 0.00017 MirTarget -0.31 0.00045 NA
120 hsa-let-7e-5p CD59 0.41 0.19626 -0.92 0.00017 MirTarget -0.18 0.00186 NA
121 hsa-let-7f-5p CD59 0.63 0.0345 -0.92 0.00017 MirTarget -0.21 0.00038 NA
122 hsa-let-7g-5p CD59 0.33 0.24114 -0.92 0.00017 MirTarget -0.24 0.00016 NA
123 hsa-miR-141-3p CD59 1.46 0.00116 -0.92 0.00017 mirMAP -0.14 0.00023 NA
124 hsa-miR-200a-3p CD59 0.72 0.19391 -0.92 0.00017 mirMAP -0.11 0.00094 NA
125 hsa-miR-335-3p CD59 2.52 0 -0.92 0.00017 mirMAP -0.21 0 NA
126 hsa-miR-92a-3p CD59 1.22 1.0E-5 -0.92 0.00017 miRNAWalker2 validate -0.36 0 NA
127 hsa-miR-98-5p CD59 0.92 3.0E-5 -0.92 0.00017 MirTarget -0.34 2.0E-5 NA
128 hsa-miR-126-5p CDH11 0.42 0.07532 0.76 0.10308 mirMAP -0.65 0 NA
129 hsa-miR-139-5p CDH11 -1.83 0 0.76 0.10308 miRanda -0.46 1.0E-5 NA
130 hsa-miR-200b-3p CDH11 0.97 0.0595 0.76 0.10308 TargetScan -0.28 1.0E-5 NA
131 hsa-miR-32-3p CDH11 0.58 0.11837 0.76 0.10308 mirMAP -0.35 0.00053 NA
132 hsa-miR-335-5p CDH11 1.6 6.0E-5 0.76 0.10308 miRNAWalker2 validate -0.28 0.00056 NA
133 hsa-miR-362-3p CDH11 -0.03 0.91378 0.76 0.10308 miRanda -0.38 0.00022 NA
134 hsa-miR-429 CDH11 1.4 0.009 0.76 0.10308 PITA; miRanda -0.27 1.0E-5 NA
135 hsa-miR-500a-5p CDH11 0 0.99212 0.76 0.10308 mirMAP -0.33 0.00084 NA
136 hsa-miR-577 CDH11 0.91 0.22561 0.76 0.10308 mirMAP -0.19 3.0E-5 NA
137 hsa-miR-7-1-3p CDH11 0.71 0.04123 0.76 0.10308 mirMAP -0.3 0.00177 NA
138 hsa-miR-194-5p CDH2 -0.13 0.90607 -3.92 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.31 0 21845495; 20979124 The results of real-time PCR and western blot highlighted that miR-194 interacted with N-cadherin and negatively regulated its expression at the translational level;The overexpression of miR-194 in liver mesenchymal-like cancer cells reduced the expression of the mesenchymal cell marker N-cadherin and suppressed invasion and migration of the mesenchymal-like cancer cells both in vitro and in vivo
139 hsa-miR-27b-5p CDH2 0.68 0.01497 -3.92 0 miRNAWalker2 validate -0.62 0.00259 NA
140 hsa-miR-320a CDH2 0.59 0.0119 -3.92 0 MirTarget; PITA; miRanda; miRNATAP -0.63 0.00994 NA
141 hsa-miR-320b CDH2 1.11 0.0005 -3.92 0 MirTarget; PITA; miRanda; miRNATAP -0.61 0.00059 NA
142 hsa-miR-320c CDH2 0.46 0.24061 -3.92 0 MirTarget; PITA; miRanda; miRNATAP -0.45 0.0083 NA
143 hsa-miR-429 CDH2 1.4 0.009 -3.92 0 miRanda -0.63 0 NA
144 hsa-miR-532-3p CDH2 0.55 0.09755 -3.92 0 PITA -0.89 0 NA
145 hsa-miR-615-3p CDH2 2.83 3.0E-5 -3.92 0 miRNAWalker2 validate -0.39 0.00058 NA
146 hsa-miR-624-5p CDH2 1.03 0.00109 -3.92 0 MirTarget -0.61 0.00121 NA
147 hsa-miR-7-1-3p CDH2 0.71 0.04123 -3.92 0 mirMAP -0.74 0 NA
148 hsa-miR-452-5p CDH6 2.09 0.00026 0.47 0.26052 mirMAP -0.15 0.00393 NA
149 hsa-miR-944 CDH6 3.33 0.01778 0.47 0.26052 PITA; miRNATAP -0.1 2.0E-5 NA
150 hsa-miR-126-5p COL11A1 0.42 0.07532 5.54 0 MirTarget; mirMAP -2.36 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR STRUCTURE ORGANIZATION 61 304 3.977e-69 1.85e-65
2 TISSUE DEVELOPMENT 72 1518 2.256e-37 5.248e-34
3 CARDIOVASCULAR SYSTEM DEVELOPMENT 53 788 4.729e-34 5.501e-31
4 CIRCULATORY SYSTEM DEVELOPMENT 53 788 4.729e-34 5.501e-31
5 VASCULATURE DEVELOPMENT 42 469 9.907e-32 9.219e-29
6 BIOLOGICAL ADHESION 55 1032 3.215e-30 2.493e-27
7 ORGAN MORPHOGENESIS 49 841 1.786e-28 1.187e-25
8 BLOOD VESSEL MORPHOGENESIS 35 364 1.909e-27 1.111e-24
9 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 49 957 6.037e-26 3.121e-23
10 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 62 1672 1.212e-25 5.641e-23
11 REGULATION OF CELLULAR COMPONENT MOVEMENT 43 771 4.14e-24 1.751e-21
12 LOCOMOTION 50 1114 6.31e-24 2.447e-21
13 REGULATION OF CELL ADHESION 39 629 1.75e-23 6.263e-21
14 RESPONSE TO WOUNDING 37 563 3.827e-23 1.187e-20
15 ANGIOGENESIS 29 293 3.807e-23 1.187e-20
16 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 52 1275 4.976e-23 1.447e-20
17 CELL DEVELOPMENT 53 1426 1.209e-21 3.308e-19
18 POSITIVE REGULATION OF LOCOMOTION 31 420 6.805e-21 1.508e-18
19 SKELETAL SYSTEM DEVELOPMENT 32 455 6.389e-21 1.508e-18
20 CELL MOTILITY 41 835 6.609e-21 1.508e-18
21 LOCALIZATION OF CELL 41 835 6.609e-21 1.508e-18
22 TISSUE MORPHOGENESIS 34 533 7.325e-21 1.549e-18
23 REGULATION OF CELL DIFFERENTIATION 53 1492 9.434e-21 1.908e-18
24 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 17 79 7.581e-20 1.47e-17
25 WOUND HEALING 31 470 1.81e-19 3.369e-17
26 RESPONSE TO GROWTH FACTOR 31 475 2.458e-19 4.399e-17
27 REGULATION OF CELL PROLIFERATION 51 1496 3.801e-19 6.55e-17
28 RESPONSE TO ENDOGENOUS STIMULUS 50 1450 5.862e-19 9.741e-17
29 REGULATION OF CELL SUBSTRATE ADHESION 21 173 7.969e-19 1.279e-16
30 MULTICELLULAR ORGANISM METABOLIC PROCESS 17 93 1.484e-18 2.301e-16
31 COLLAGEN FIBRIL ORGANIZATION 13 38 2.12e-18 3.183e-16
32 EPITHELIUM DEVELOPMENT 40 945 4.145e-18 6.026e-16
33 POSITIVE REGULATION OF CELL ADHESION 27 376 5.775e-18 8.143e-16
34 POSITIVE REGULATION OF RESPONSE TO STIMULUS 56 1929 6.358e-18 8.701e-16
35 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 41 1021 9.407e-18 1.251e-15
36 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 22 229 1.846e-17 2.386e-15
37 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 36 801 4.038e-17 5.078e-15
38 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 46 1360 4.702e-17 5.757e-15
39 EXTRACELLULAR MATRIX DISASSEMBLY 15 76 4.902e-17 5.848e-15
40 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 42 1142 8.053e-17 9.367e-15
41 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 39 983 1.05e-16 1.191e-14
42 OSSIFICATION 22 251 1.312e-16 1.453e-14
43 CONNECTIVE TISSUE DEVELOPMENT 20 194 1.458e-16 1.577e-14
44 NEGATIVE REGULATION OF CELL COMMUNICATION 42 1192 3.67e-16 3.881e-14
45 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 45 1395 6.624e-16 6.85e-14
46 CELL JUNCTION ORGANIZATION 19 185 9.354e-16 9.461e-14
47 RESPONSE TO EXTERNAL STIMULUS 51 1821 1.418e-15 1.404e-13
48 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 51 1848 2.576e-15 2.497e-13
49 NEUROGENESIS 44 1402 4.098e-15 3.891e-13
50 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 37 1008 8.616e-15 8.018e-13
51 RESPONSE TO OXYGEN CONTAINING COMPOUND 43 1381 1.207e-14 1.101e-12
52 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 27 513 1.307e-14 1.169e-12
53 ENDODERMAL CELL DIFFERENTIATION 11 40 1.512e-14 1.327e-12
54 FORMATION OF PRIMARY GERM LAYER 15 110 1.598e-14 1.377e-12
55 ENDODERM DEVELOPMENT 13 71 1.803e-14 1.526e-12
56 REGULATION OF CELL DEATH 44 1472 2.325e-14 1.932e-12
57 CELL SUBSTRATE ADHESION 17 164 2.802e-14 2.287e-12
58 REGULATION OF PHOSPHORUS METABOLIC PROCESS 46 1618 3.162e-14 2.537e-12
59 RESPONSE TO LIPID 34 888 3.836e-14 3.025e-12
60 EMBRYONIC MORPHOGENESIS 27 539 4.309e-14 3.341e-12
61 NEGATIVE REGULATION OF LOCOMOTION 20 263 5.219e-14 3.963e-12
62 CELL MATRIX ADHESION 15 119 5.28e-14 3.963e-12
63 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 16 144 5.54e-14 4.092e-12
64 POSITIVE REGULATION OF CHEMOTAXIS 15 120 5.992e-14 4.357e-12
65 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 14 99 7.373e-14 5.278e-12
66 CARTILAGE DEVELOPMENT 16 147 7.684e-14 5.417e-12
67 POSITIVE REGULATION OF CELL COMMUNICATION 44 1532 9.474e-14 6.58e-12
68 NEGATIVE REGULATION OF CELL DIFFERENTIATION 28 609 1.149e-13 7.862e-12
69 POSITIVE REGULATION OF CELL PROLIFERATION 32 814 1.194e-13 8.054e-12
70 INTEGRIN MEDIATED SIGNALING PATHWAY 13 82 1.281e-13 8.517e-12
71 POSITIVE REGULATION OF CELL DIFFERENTIATION 32 823 1.61e-13 1.055e-11
72 GASTRULATION 16 155 1.775e-13 1.147e-11
73 ENDODERM FORMATION 11 50 2.277e-13 1.451e-11
74 RESPONSE TO HORMONE 33 893 2.602e-13 1.636e-11
75 CELLULAR COMPONENT MORPHOGENESIS 33 900 3.229e-13 2.003e-11
76 NEGATIVE REGULATION OF CELL PROLIFERATION 28 643 4.324e-13 2.647e-11
77 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 37 1152 5.136e-13 3.104e-11
78 NEURON DIFFERENTIATION 32 874 8.142e-13 4.857e-11
79 REGULATION OF CELL GROWTH 22 391 1.214e-12 7.149e-11
80 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 14 121 1.258e-12 7.317e-11
81 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 44 1656 1.389e-12 7.981e-11
82 REGULATION OF CELL DEVELOPMENT 31 836 1.412e-12 8.013e-11
83 EMBRYO DEVELOPMENT 32 894 1.489e-12 8.348e-11
84 RESPONSE TO MECHANICAL STIMULUS 17 210 1.648e-12 9.127e-11
85 REGULATION OF CHEMOTAXIS 16 180 1.827e-12 1e-10
86 REGULATION OF EPITHELIAL CELL PROLIFERATION 19 285 2.419e-12 1.309e-10
87 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 34 1036 2.99e-12 1.581e-10
88 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 34 1036 2.99e-12 1.581e-10
89 TUBE DEVELOPMENT 25 552 3.811e-12 1.992e-10
90 REGULATION OF PROTEIN MODIFICATION PROCESS 44 1710 4.117e-12 2.129e-10
91 NEGATIVE REGULATION OF CELL DEATH 31 872 4.197e-12 2.146e-10
92 REGULATION OF MAPK CASCADE 27 660 5.082e-12 2.57e-10
93 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 34 1087 1.121e-11 5.609e-10
94 NEURON DEVELOPMENT 27 687 1.275e-11 6.314e-10
95 MORPHOGENESIS OF AN EPITHELIUM 21 400 1.518e-11 7.436e-10
96 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 16 207 1.551e-11 7.516e-10
97 RESPONSE TO ACID CHEMICAL 19 319 1.736e-11 8.327e-10
98 RESPONSE TO STEROID HORMONE 23 497 1.953e-11 9.272e-10
99 GROWTH 21 410 2.411e-11 1.133e-09
100 REGULATION OF CELL MORPHOGENESIS 24 552 2.51e-11 1.168e-09
101 SINGLE ORGANISM CELL ADHESION 22 459 2.827e-11 1.302e-09
102 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 14 154 3.468e-11 1.582e-09
103 HEART DEVELOPMENT 22 466 3.786e-11 1.694e-09
104 CELL SUBSTRATE JUNCTION ASSEMBLY 9 41 3.761e-11 1.694e-09
105 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 19 337 4.475e-11 1.983e-09
106 RESPONSE TO ABIOTIC STIMULUS 32 1024 5.17e-11 2.248e-09
107 UROGENITAL SYSTEM DEVELOPMENT 18 299 5.126e-11 2.248e-09
108 MUSCLE STRUCTURE DEVELOPMENT 21 432 6.371e-11 2.745e-09
109 RESPONSE TO ORGANIC CYCLIC COMPOUND 30 917 7.57e-11 3.231e-09
110 REGULATION OF VASCULATURE DEVELOPMENT 16 233 9.181e-11 3.884e-09
111 REGULATION OF EPITHELIAL CELL MIGRATION 14 166 9.534e-11 3.986e-09
112 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 30 926 9.594e-11 3.986e-09
113 RESPONSE TO ALCOHOL 19 362 1.518e-10 6.251e-09
114 AMINOGLYCAN CATABOLIC PROCESS 10 68 2.014e-10 8.222e-09
115 SINGLE ORGANISM CATABOLIC PROCESS 30 957 2.122e-10 8.586e-09
116 TAXIS 21 464 2.368e-10 9.417e-09
117 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 38 1492 2.348e-10 9.417e-09
118 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 17 296 3.757e-10 1.481e-08
119 REGULATION OF GROWTH 24 633 4.102e-10 1.604e-08
120 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 25 689 4.246e-10 1.646e-08
121 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 26 750 4.838e-10 1.858e-08
122 RESPONSE TO VITAMIN 11 98 4.872e-10 1.858e-08
123 REGULATION OF RESPONSE TO STRESS 37 1468 5.736e-10 2.152e-08
124 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 14 190 5.735e-10 2.152e-08
125 REGULATION OF PEPTIDASE ACTIVITY 19 392 5.8e-10 2.159e-08
126 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 32 1135 6.932e-10 2.56e-08
127 CELL JUNCTION ASSEMBLY 12 129 7.044e-10 2.581e-08
128 NEURON PROJECTION DEVELOPMENT 22 545 7.392e-10 2.687e-08
129 REGULATION OF CELLULAR COMPONENT BIOGENESIS 26 767 7.787e-10 2.809e-08
130 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 11 103 8.373e-10 2.997e-08
131 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 11 104 9.297e-10 3.302e-08
132 REGULATION OF NEURON DIFFERENTIATION 22 554 1.003e-09 3.535e-08
133 REGULATION OF NEURON PROJECTION DEVELOPMENT 19 408 1.129e-09 3.949e-08
134 CELL GROWTH 12 135 1.194e-09 4.145e-08
135 MORPHOGENESIS OF A BRANCHING STRUCTURE 13 167 1.233e-09 4.25e-08
136 PLATELET DEGRANULATION 11 107 1.265e-09 4.327e-08
137 REGULATION OF TISSUE REMODELING 9 62 1.88e-09 6.386e-08
138 RESPONSE TO AMINO ACID 11 112 2.068e-09 6.972e-08
139 REGULATION OF HYDROLASE ACTIVITY 34 1327 2.194e-09 7.345e-08
140 REGULATION OF ENDOTHELIAL CELL MIGRATION 11 114 2.5e-09 8.309e-08
141 REGULATION OF OSSIFICATION 13 178 2.696e-09 8.896e-08
142 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 27 876 2.778e-09 9.103e-08
143 NEGATIVE REGULATION OF MOLECULAR FUNCTION 30 1079 3.577e-09 1.164e-07
144 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 9 67 3.827e-09 1.237e-07
145 NEGATIVE REGULATION OF CELL DEVELOPMENT 16 303 4.25e-09 1.364e-07
146 SENSORY ORGAN DEVELOPMENT 20 493 4.287e-09 1.366e-07
147 CELL PROJECTION ORGANIZATION 27 902 5.181e-09 1.64e-07
148 CELL CELL ADHESION 22 608 5.539e-09 1.741e-07
149 RESPONSE TO OXYGEN LEVELS 16 311 6.16e-09 1.924e-07
150 REGULATION OF CELL PROJECTION ORGANIZATION 21 558 6.407e-09 1.978e-07
151 REGULATION OF LEUKOCYTE CHEMOTAXIS 10 96 6.42e-09 1.978e-07
152 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 10 98 7.861e-09 2.406e-07
153 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 15 274 8.174e-09 2.486e-07
154 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 25 799 8.583e-09 2.593e-07
155 REGENERATION 12 161 8.942e-09 2.684e-07
156 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 23 684 9.568e-09 2.854e-07
157 TUBE MORPHOGENESIS 16 323 1.053e-08 3.121e-07
158 CELLULAR RESPONSE TO AMINO ACID STIMULUS 8 53 1.116e-08 3.285e-07
159 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 10 102 1.162e-08 3.402e-07
160 SKELETAL SYSTEM MORPHOGENESIS 13 201 1.173e-08 3.41e-07
161 NEGATIVE REGULATION OF PHOSPHORYLATION 18 422 1.247e-08 3.605e-07
162 AMINOGLYCAN METABOLIC PROCESS 12 166 1.262e-08 3.625e-07
163 DEVELOPMENTAL GROWTH 16 333 1.617e-08 4.616e-07
164 HEART MORPHOGENESIS 13 212 2.215e-08 6.285e-07
165 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 7 38 2.234e-08 6.301e-07
166 CELLULAR RESPONSE TO ACID CHEMICAL 12 175 2.281e-08 6.393e-07
167 RESPONSE TO CORTICOSTEROID 12 176 2.43e-08 6.772e-07
168 POSITIVE REGULATION OF CELL DEATH 21 605 2.599e-08 7.199e-07
169 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 11 144 2.941e-08 8.098e-07
170 RESPONSE TO ESTROGEN 13 218 3.085e-08 8.442e-07
171 REGULATION OF IMMUNE SYSTEM PROCESS 33 1403 3.177e-08 8.644e-07
172 POSITIVE REGULATION OF ENDOCYTOSIS 10 114 3.414e-08 9.236e-07
173 REGULATION OF BODY FLUID LEVELS 19 506 3.692e-08 9.93e-07
174 NEGATIVE REGULATION OF CELL ADHESION 13 223 4.032e-08 1.078e-06
175 REGULATION OF LEUKOCYTE MIGRATION 11 149 4.189e-08 1.114e-06
176 REGULATION OF CARTILAGE DEVELOPMENT 8 63 4.548e-08 1.199e-06
177 REPRODUCTIVE SYSTEM DEVELOPMENT 17 408 4.561e-08 1.199e-06
178 REGULATION OF BONE REMODELING 7 42 4.646e-08 1.215e-06
179 CELLULAR COMPONENT DISASSEMBLY 19 515 4.875e-08 1.267e-06
180 REGULATION OF CELL MATRIX ADHESION 9 90 5.382e-08 1.391e-06
181 REGULATION OF RESPONSE TO WOUNDING 17 413 5.438e-08 1.398e-06
182 CELLULAR RESPONSE TO VITAMIN 6 26 5.575e-08 1.425e-06
183 RESPONSE TO NUTRIENT 12 191 6.017e-08 1.522e-06
184 RESPONSE TO REACTIVE OXYGEN SPECIES 12 191 6.017e-08 1.522e-06
185 POSITIVE REGULATION OF MAPK CASCADE 18 470 6.432e-08 1.618e-06
186 MUSCLE ORGAN DEVELOPMENT 14 277 7.12e-08 1.781e-06
187 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 24 829 7.609e-08 1.893e-06
188 EYE DEVELOPMENT 15 326 8.18e-08 2.025e-06
189 REGULATION OF CELL JUNCTION ASSEMBLY 8 68 8.384e-08 2.064e-06
190 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 9 95 8.647e-08 2.118e-06
191 OSTEOBLAST DIFFERENTIATION 10 126 8.884e-08 2.164e-06
192 REGULATION OF PROTEOLYSIS 22 711 8.946e-08 2.168e-06
193 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 5 15 9.801e-08 2.363e-06
194 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 11 162 9.898e-08 2.374e-06
195 ADHERENS JUNCTION ORGANIZATION 8 71 1.182e-07 2.82e-06
196 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 10 131 1.284e-07 3.049e-06
197 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 7 49 1.41e-07 3.33e-06
198 REGULATION OF AXONOGENESIS 11 168 1.434e-07 3.369e-06
199 CELL PROLIFERATION 21 672 1.53e-07 3.579e-06
200 INTERACTION WITH HOST 10 134 1.59e-07 3.699e-06
201 NEGATIVE REGULATION OF CELL GROWTH 11 170 1.617e-07 3.742e-06
202 GLAND DEVELOPMENT 16 395 1.702e-07 3.92e-06
203 CELL DEATH 26 1001 1.744e-07 3.998e-06
204 ARTERY DEVELOPMENT 8 75 1.823e-07 4.157e-06
205 POSITIVE REGULATION OF TRANSPORT 25 936 1.839e-07 4.173e-06
206 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 12 213 1.979e-07 4.469e-06
207 CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS 11 174 2.046e-07 4.599e-06
208 NEURON PROJECTION MORPHOGENESIS 16 402 2.157e-07 4.825e-06
209 GLIOGENESIS 11 175 2.168e-07 4.826e-06
210 CELL ACTIVATION 19 568 2.231e-07 4.944e-06
211 REGULATION OF BMP SIGNALING PATHWAY 8 77 2.242e-07 4.944e-06
212 PROTEIN COMPLEX SUBUNIT ORGANIZATION 33 1527 2.312e-07 5.074e-06
213 CARDIAC MUSCLE TISSUE DEVELOPMENT 10 140 2.398e-07 5.238e-06
214 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 7 53 2.461e-07 5.334e-06
215 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 16 406 2.465e-07 5.334e-06
216 RESPONSE TO VITAMIN D 6 33 2.557e-07 5.509e-06
217 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 13 262 2.627e-07 5.611e-06
218 MUCOPOLYSACCHARIDE METABOLIC PROCESS 9 108 2.629e-07 5.611e-06
219 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 9 109 2.845e-07 6.018e-06
220 RESPONSE TO HYDROGEN PEROXIDE 9 109 2.845e-07 6.018e-06
221 SYSTEM PROCESS 36 1785 3.169e-07 6.672e-06
222 RESPONSE TO KETONE 11 182 3.217e-07 6.743e-06
223 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 8 81 3.333e-07 6.955e-06
224 REGULATION OF OSTEOBLAST DIFFERENTIATION 9 112 3.591e-07 7.46e-06
225 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 15 368 3.891e-07 8.047e-06
226 ENDOTHELIAL CELL MIGRATION 7 57 4.107e-07 8.456e-06
227 RESPONSE TO INORGANIC SUBSTANCE 17 479 4.452e-07 9.029e-06
228 TISSUE MIGRATION 8 84 4.425e-07 9.029e-06
229 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 15 372 4.463e-07 9.029e-06
230 POSITIVE CHEMOTAXIS 6 36 4.407e-07 9.029e-06
231 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 9 115 4.501e-07 9.066e-06
232 MUSCLE TISSUE DEVELOPMENT 13 275 4.565e-07 9.155e-06
233 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 18 541 5.133e-07 1.021e-05
234 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 18 541 5.133e-07 1.021e-05
235 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 11 191 5.212e-07 1.032e-05
236 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 19 602 5.397e-07 1.064e-05
237 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 10 153 5.474e-07 1.075e-05
238 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 5.809e-07 1.103e-05
239 NEGATIVE REGULATION OF PROTEOLYSIS 14 329 5.788e-07 1.103e-05
240 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 5.809e-07 1.103e-05
241 VIRAL ENTRY INTO HOST CELL 8 87 5.809e-07 1.103e-05
242 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 5.809e-07 1.103e-05
243 MOVEMENT IN HOST ENVIRONMENT 8 87 5.809e-07 1.103e-05
244 ENTRY INTO HOST 8 87 5.809e-07 1.103e-05
245 ENTRY INTO HOST CELL 8 87 5.809e-07 1.103e-05
246 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 16 437 6.569e-07 1.242e-05
247 SENSORY ORGAN MORPHOGENESIS 12 239 6.795e-07 1.28e-05
248 EPITHELIAL CELL PROLIFERATION 8 89 6.924e-07 1.299e-05
249 SULFUR COMPOUND CATABOLIC PROCESS 6 39 7.234e-07 1.346e-05
250 CELLULAR RESPONSE TO NUTRIENT 6 39 7.234e-07 1.346e-05
251 RESPONSE TO EXTRACELLULAR STIMULUS 16 441 7.408e-07 1.373e-05
252 CENTRAL NERVOUS SYSTEM DEVELOPMENT 23 872 7.474e-07 1.38e-05
253 REGULATION OF ORGAN MORPHOGENESIS 12 242 7.755e-07 1.426e-05
254 REGULATION OF ENDOCYTOSIS 11 199 7.831e-07 1.434e-05
255 CATABOLIC PROCESS 35 1773 7.951e-07 1.451e-05
256 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 12 245 8.833e-07 1.605e-05
257 REGULATION OF WOUND HEALING 9 126 9.76e-07 1.767e-05
258 AORTA DEVELOPMENT 6 41 9.835e-07 1.774e-05
259 REGULATION OF OSTEOBLAST PROLIFERATION 5 23 1.041e-06 1.864e-05
260 TRABECULA FORMATION 5 23 1.041e-06 1.864e-05
261 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 6 42 1.14e-06 2.032e-05
262 REGULATION OF TRANSPORT 35 1804 1.188e-06 2.111e-05
263 REGULATION OF POSITIVE CHEMOTAXIS 5 24 1.307e-06 2.303e-05
264 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 24 1.307e-06 2.303e-05
265 BONE TRABECULA MORPHOGENESIS 4 11 1.375e-06 2.415e-05
266 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 7 68 1.396e-06 2.443e-05
267 HEAD DEVELOPMENT 20 709 1.525e-06 2.658e-05
268 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 9 133 1.536e-06 2.667e-05
269 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 8 99 1.566e-06 2.699e-05
270 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 8 99 1.566e-06 2.699e-05
271 LEUKOCYTE MIGRATION 12 259 1.583e-06 2.717e-05
272 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 25 1.623e-06 2.776e-05
273 SECRETION 18 588 1.691e-06 2.86e-05
274 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 8 100 1.691e-06 2.86e-05
275 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 8 100 1.691e-06 2.86e-05
276 SPROUTING ANGIOGENESIS 6 45 1.734e-06 2.923e-05
277 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 11 216 1.751e-06 2.941e-05
278 POSITIVE REGULATION OF CELL DEVELOPMENT 16 472 1.798e-06 3.009e-05
279 HEMOSTASIS 13 311 1.813e-06 3.024e-05
280 REGULATION OF APOPTOTIC SIGNALING PATHWAY 14 363 1.853e-06 3.079e-05
281 AGING 12 264 1.932e-06 3.199e-05
282 CELL ADHESION MEDIATED BY INTEGRIN 4 12 2.05e-06 3.382e-05
283 RESPONSE TO NITROGEN COMPOUND 22 859 2.158e-06 3.547e-05
284 AXIS ELONGATION 5 27 2.433e-06 3.986e-05
285 REGULATED EXOCYTOSIS 11 224 2.493e-06 4.07e-05
286 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 22 867 2.508e-06 4.08e-05
287 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 13 321 2.57e-06 4.167e-05
288 SECRETION BY CELL 16 486 2.62e-06 4.232e-05
289 AMINOGLYCAN BIOSYNTHETIC PROCESS 8 107 2.821e-06 4.542e-05
290 INDUCTION OF POSITIVE CHEMOTAXIS 4 13 2.942e-06 4.704e-05
291 NEGATIVE REGULATION OF BONE REMODELING 4 13 2.942e-06 4.704e-05
292 REGULATION OF ADHERENS JUNCTION ORGANIZATION 6 50 3.27e-06 5.211e-05
293 EPITHELIAL CELL DIFFERENTIATION 16 495 3.313e-06 5.261e-05
294 RESPONSE TO ESTRADIOL 9 146 3.33e-06 5.271e-05
295 MUSCLE CONTRACTION 11 233 3.645e-06 5.749e-05
296 ARTERY MORPHOGENESIS 6 51 3.681e-06 5.787e-05
297 IMMUNE SYSTEM PROCESS 36 1984 3.83e-06 5.98e-05
298 MUSCLE SYSTEM PROCESS 12 282 3.817e-06 5.98e-05
299 CELLULAR RESPONSE TO VITAMIN D 4 14 4.092e-06 6.368e-05
300 NEGATIVE REGULATION OF GROWTH 11 236 4.121e-06 6.391e-05
301 NEGATIVE REGULATION OF B CELL ACTIVATION 5 30 4.211e-06 6.509e-05
302 REGULATION OF ERK1 AND ERK2 CASCADE 11 238 4.467e-06 6.883e-05
303 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 6 53 4.63e-06 7.086e-05
304 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 6 53 4.63e-06 7.086e-05
305 CELLULAR RESPONSE TO ALCOHOL 8 115 4.843e-06 7.388e-05
306 RESPONSE TO FIBROBLAST GROWTH FACTOR 8 116 5.166e-06 7.83e-05
307 FEMALE SEX DIFFERENTIATION 8 116 5.166e-06 7.83e-05
308 INFLAMMATORY RESPONSE 15 454 5.234e-06 7.881e-05
309 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 14 397 5.22e-06 7.881e-05
310 ORGANONITROGEN COMPOUND CATABOLIC PROCESS 13 343 5.295e-06 7.947e-05
311 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 10 197 5.393e-06 8.068e-05
312 CELLULAR RESPONSE TO LIPID 15 457 5.665e-06 8.448e-05
313 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 9 156 5.732e-06 8.52e-05
314 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 6 55 5.768e-06 8.547e-05
315 POSITIVE REGULATION OF OSSIFICATION 7 84 5.846e-06 8.636e-05
316 REGULATION OF KINASE ACTIVITY 20 776 5.936e-06 8.741e-05
317 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 10 200 6.164e-06 9.047e-05
318 IMMUNE SYSTEM DEVELOPMENT 17 582 6.218e-06 9.098e-05
319 PEPTIDE CROSS LINKING 6 56 6.416e-06 9.33e-05
320 EPITHELIAL TO MESENCHYMAL TRANSITION 6 56 6.416e-06 9.33e-05
321 NEURON PROJECTION REGENERATION 5 33 6.874e-06 9.965e-05
322 RESPONSE TO OXIDATIVE STRESS 13 352 7e-06 0.0001012
323 REGULATION OF B CELL ACTIVATION 8 121 7.067e-06 0.0001018
324 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 4 16 7.346e-06 0.0001055
325 TISSUE REMODELING 7 87 7.389e-06 0.0001058
326 NEURON PROJECTION GUIDANCE 10 205 7.662e-06 0.0001094
327 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 9 162 7.789e-06 0.0001105
328 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 162 7.789e-06 0.0001105
329 REGULATION OF STEM CELL PROLIFERATION 7 88 7.972e-06 0.0001128
330 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 6 59 8.725e-06 0.000123
331 KIDNEY EPITHELIUM DEVELOPMENT 8 125 8.986e-06 0.0001263
332 NEGATIVE REGULATION OF PROTEIN PROCESSING 5 35 9.279e-06 0.0001293
333 NEGATIVE REGULATION OF PROTEIN MATURATION 5 35 9.279e-06 0.0001293
334 MESONEPHROS DEVELOPMENT 7 90 9.255e-06 0.0001293
335 BRANCH ELONGATION OF AN EPITHELIUM 4 17 9.544e-06 0.0001318
336 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 4 17 9.544e-06 0.0001318
337 NEGATIVE REGULATION OF TISSUE REMODELING 4 17 9.544e-06 0.0001318
338 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 6 60 9.629e-06 0.0001326
339 CIRCULATORY SYSTEM PROCESS 13 366 1.062e-05 0.0001458
340 MULTI MULTICELLULAR ORGANISM PROCESS 10 213 1.071e-05 0.0001466
341 REGULATION OF CELL ACTIVATION 15 484 1.122e-05 0.0001531
342 CELLULAR RESPONSE TO EXTERNAL STIMULUS 11 264 1.192e-05 0.0001622
343 SEX DIFFERENTIATION 11 266 1.279e-05 0.0001735
344 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 17 616 1.301e-05 0.000176
345 REGULATION OF LYMPHOCYTE DIFFERENTIATION 8 132 1.34e-05 0.0001808
346 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 5 38 1.407e-05 0.0001892
347 HOMEOSTASIS OF NUMBER OF CELLS 9 175 1.45e-05 0.0001944
348 GLAND MORPHOGENESIS 7 97 1.517e-05 0.0002028
349 TRABECULA MORPHOGENESIS 5 39 1.603e-05 0.0002125
350 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 5 39 1.603e-05 0.0002125
351 NEGATIVE CHEMOTAXIS 5 39 1.603e-05 0.0002125
352 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 7 98 1.622e-05 0.0002144
353 EYE MORPHOGENESIS 8 136 1.666e-05 0.0002196
354 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 6 66 1.678e-05 0.00022
355 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 6 66 1.678e-05 0.00022
356 CELL PART MORPHOGENESIS 17 633 1.845e-05 0.0002411
357 REGULATION OF MONOCYTE CHEMOTAXIS 4 20 1.906e-05 0.0002484
358 TELENCEPHALON DEVELOPMENT 10 228 1.933e-05 0.0002512
359 REPRODUCTION 26 1297 2.023e-05 0.0002622
360 RESPONSE TO METAL ION 12 333 2.033e-05 0.0002628
361 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 5 41 2.059e-05 0.0002654
362 REGULATION OF LEUKOCYTE DIFFERENTIATION 10 232 2.244e-05 0.0002885
363 PLATELET ACTIVATION 8 142 2.278e-05 0.0002921
364 CELL AGGREGATION 4 21 2.339e-05 0.0002982
365 CARTILAGE CONDENSATION 4 21 2.339e-05 0.0002982
366 MUSCLE ORGAN MORPHOGENESIS 6 70 2.357e-05 0.0002997
367 CARDIAC CHAMBER MORPHOGENESIS 7 104 2.391e-05 0.0003031
368 RESPONSE TO CYTOKINE 18 714 2.402e-05 0.0003037
369 ODONTOGENESIS 7 105 2.544e-05 0.0003208
370 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 10 236 2.598e-05 0.0003267
371 MORPHOGENESIS OF AN EPITHELIAL SHEET 5 43 2.61e-05 0.0003273
372 MUSCLE CELL DIFFERENTIATION 10 237 2.693e-05 0.0003369
373 MESENCHYME DEVELOPMENT 9 190 2.784e-05 0.0003473
374 REGULATION OF B CELL DIFFERENTIATION 4 22 2.841e-05 0.0003516
375 AORTA MORPHOGENESIS 4 22 2.841e-05 0.0003516
376 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 4 22 2.841e-05 0.0003516
377 REGULATION OF VESICLE MEDIATED TRANSPORT 14 462 2.849e-05 0.0003517
378 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 6 73 2.999e-05 0.0003692
379 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 23 3.417e-05 0.0004152
380 RESPONSE TO INCREASED OXYGEN LEVELS 4 23 3.417e-05 0.0004152
381 EPIBOLY 4 23 3.417e-05 0.0004152
382 RESPONSE TO HYPEROXIA 4 23 3.417e-05 0.0004152
383 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 4 23 3.417e-05 0.0004152
384 RESPIRATORY SYSTEM DEVELOPMENT 9 197 3.698e-05 0.000448
385 CELL CYCLE ARREST 8 154 4.078e-05 0.0004888
386 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 5 47 4.05e-05 0.0004888
387 OVULATION CYCLE 7 113 4.087e-05 0.0004888
388 AMEBOIDAL TYPE CELL MIGRATION 8 154 4.078e-05 0.0004888
389 DEVELOPMENTAL CELL GROWTH 6 77 4.066e-05 0.0004888
390 NEGATIVE REGULATION OF KINASE ACTIVITY 10 250 4.238e-05 0.0005056
391 RESPONSE TO AXON INJURY 5 48 4.491e-05 0.0005345
392 LEUKOCYTE CELL CELL ADHESION 10 255 5.007e-05 0.0005943
393 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 6 80 5.05e-05 0.0005964
394 CELLULAR RESPONSE TO MECHANICAL STIMULUS 6 80 5.05e-05 0.0005964
395 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 7 117 5.107e-05 6e-04
396 MAMMARY GLAND DEVELOPMENT 7 117 5.107e-05 6e-04
397 REGULATION OF WNT SIGNALING PATHWAY 11 310 5.213e-05 0.0006095
398 EXOCYTOSIS 11 310 5.213e-05 0.0006095
399 MESODERM DEVELOPMENT 7 118 5.392e-05 0.0006287
400 REGULATION OF FIBROBLAST PROLIFERATION 6 81 5.417e-05 0.0006302
401 FACE DEVELOPMENT 5 50 5.485e-05 0.0006364
402 REGULATION OF ACTIN FILAMENT BASED PROCESS 11 312 5.524e-05 0.0006394
403 REGULATION OF CELLULAR RESPONSE TO STRESS 17 691 5.538e-05 0.0006395
404 REGULATION OF MESONEPHROS DEVELOPMENT 4 26 5.66e-05 0.0006503
405 MESODERMAL CELL DIFFERENTIATION 4 26 5.66e-05 0.0006503
406 RESPONSE TO DRUG 13 431 5.814e-05 0.0006664
407 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 51 6.041e-05 0.0006906
408 SKIN DEVELOPMENT 9 211 6.301e-05 0.0007186
409 CELLULAR RESPONSE TO ABIOTIC STIMULUS 10 263 6.483e-05 0.0007376
410 APOPTOTIC CELL CLEARANCE 4 27 6.602e-05 0.0007438
411 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 27 6.602e-05 0.0007438
412 SUBSTRATE DEPENDENT CELL MIGRATION 4 27 6.602e-05 0.0007438
413 HETEROTYPIC CELL CELL ADHESION 4 27 6.602e-05 0.0007438
414 CELLULAR RESPONSE TO IONIZING RADIATION 5 52 6.639e-05 0.0007462
415 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 13 437 6.688e-05 0.0007499
416 REGULATION OF MAP KINASE ACTIVITY 11 319 6.74e-05 0.0007538
417 POSITIVE REGULATION OF GENE EXPRESSION 30 1733 6.923e-05 0.0007725
418 PALATE DEVELOPMENT 6 85 7.106e-05 0.000791
419 NEURON PROJECTION EXTENSION 5 53 7.283e-05 0.000803
420 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 5 53 7.283e-05 0.000803
421 MAMMARY GLAND EPITHELIUM DEVELOPMENT 5 53 7.283e-05 0.000803
422 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 5 53 7.283e-05 0.000803
423 RESPONSE TO CARBOHYDRATE 8 168 7.542e-05 0.0008297
424 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 6 86 7.588e-05 0.0008327
425 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 15 573 7.796e-05 0.0008535
426 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 11 8.511e-05 0.0009231
427 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 3 11 8.511e-05 0.0009231
428 POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION 3 11 8.511e-05 0.0009231
429 OLFACTORY BULB INTERNEURON DEVELOPMENT 3 11 8.511e-05 0.0009231
430 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 6 88 8.629e-05 0.0009337
431 REGULATION OF KIDNEY DEVELOPMENT 5 55 8.713e-05 0.0009406
432 MUSCLE CELL DEVELOPMENT 7 128 9.028e-05 0.0009724
433 STRIATED MUSCLE CELL DIFFERENTIATION 8 173 9.259e-05 0.000995
434 SMAD PROTEIN SIGNAL TRANSDUCTION 5 56 9.504e-05 0.001017
435 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 5 56 9.504e-05 0.001017
436 REGULATION OF TRANSFERASE ACTIVITY 20 946 9.855e-05 0.001052
437 NEGATIVE REGULATION OF CELL MATRIX ADHESION 4 30 0.0001011 0.001074
438 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 4 30 0.0001011 0.001074
439 EMBRYONIC ORGAN MORPHOGENESIS 10 279 0.0001057 0.00112
440 NEGATIVE REGULATION OF TRANSPORT 13 458 0.0001071 0.001132
441 POSITIVE REGULATION OF CATALYTIC ACTIVITY 27 1518 0.000108 0.00114
442 POSITIVE REGULATION OF CELL DIVISION 7 132 0.0001095 0.001153
443 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 3 12 0.0001128 0.001172
444 ROUNDABOUT SIGNALING PATHWAY 3 12 0.0001128 0.001172
445 AXON EXTENSION INVOLVED IN AXON GUIDANCE 3 12 0.0001128 0.001172
446 NEGATIVE REGULATION OF WOUND HEALING 5 58 0.0001125 0.001172
447 HEMIDESMOSOME ASSEMBLY 3 12 0.0001128 0.001172
448 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 3 12 0.0001128 0.001172
449 HYALURONAN METABOLIC PROCESS 4 31 0.0001154 0.001196
450 ACTIN FILAMENT BASED MOVEMENT 6 93 0.0001174 0.001211
451 REGULATION OF DNA BINDING 6 93 0.0001174 0.001211
452 REGULATION OF BINDING 10 283 0.0001188 0.001223
453 REGULATION OF CELLULAR LOCALIZATION 24 1277 0.0001194 0.001226
454 RESPONSE TO BMP 6 94 0.0001245 0.001273
455 CELLULAR RESPONSE TO BMP STIMULUS 6 94 0.0001245 0.001273
456 POSITIVE REGULATION OF MOLECULAR FUNCTION 30 1791 0.0001251 0.001277
457 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 9 232 0.0001299 0.001323
458 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 32 0.000131 0.001331
459 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 5 60 0.0001323 0.001339
460 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 5 60 0.0001323 0.001339
461 EMBRYONIC ORGAN DEVELOPMENT 12 406 0.0001361 0.001374
462 REGULATION OF DEVELOPMENTAL GROWTH 10 289 0.000141 0.00142
463 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 30 1805 0.0001436 0.001444
464 CELLULAR RESPONSE TO CYTOKINE STIMULUS 15 606 0.0001445 0.001449
465 DERMATAN SULFATE METABOLIC PROCESS 3 13 0.0001458 0.001455
466 EXTRACELLULAR FIBRIL ORGANIZATION 3 13 0.0001458 0.001455
467 REGULATION OF BONE RESORPTION 4 33 0.0001481 0.001476
468 LEUKOCYTE DIFFERENTIATION 10 292 0.0001533 0.001525
469 POSITIVE REGULATION OF HYDROLASE ACTIVITY 19 905 0.0001627 0.001614
470 RESPONSE TO PROSTAGLANDIN 4 34 0.0001668 0.001652
471 RHYTHMIC PROCESS 10 298 0.0001808 0.001786
472 FOREBRAIN DEVELOPMENT 11 357 0.0001814 0.001789
473 REGULATION OF FIBRINOLYSIS 3 14 0.0001844 0.001802
474 CHONDROITIN SULFATE CATABOLIC PROCESS 3 14 0.0001844 0.001802
475 POSITIVE REGULATION OF P38MAPK CASCADE 3 14 0.0001844 0.001802
476 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 3 14 0.0001844 0.001802
477 REGULATION OF EXTENT OF CELL GROWTH 6 101 0.0001849 0.001804
478 CARDIAC CHAMBER DEVELOPMENT 7 144 0.0001881 0.00182
479 REGULATION OF JAK STAT CASCADE 7 144 0.0001881 0.00182
480 BONE REMODELING 4 35 0.0001872 0.00182
481 REGULATION OF STAT CASCADE 7 144 0.0001881 0.00182
482 CELLULAR RESPONSE TO HORMONE STIMULUS 14 552 0.0001886 0.00182
483 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 14 554 0.0001957 0.001885
484 REGULATION OF MUSCLE ORGAN DEVELOPMENT 6 103 0.0002058 0.001979
485 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 10 303 0.0002067 0.001983
486 MESODERM MORPHOGENESIS 5 66 0.0002082 0.001993
487 OLFACTORY LOBE DEVELOPMENT 4 36 0.0002092 0.001995
488 HEAD MORPHOGENESIS 4 36 0.0002092 0.001995
489 EAR DEVELOPMENT 8 195 0.0002112 0.00201
490 POSITIVE REGULATION OF DEFENSE RESPONSE 11 364 0.0002146 0.002037
491 POSITIVE REGULATION OF NEURON DIFFERENTIATION 10 306 0.0002237 0.002116
492 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 5 67 0.0002235 0.002116
493 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 8 197 0.0002264 0.002137
494 OLFACTORY BULB INTERNEURON DIFFERENTIATION 3 15 0.0002291 0.002154
495 HYALURONAN CATABOLIC PROCESS 3 15 0.0002291 0.002154
496 REGULATION OF CYTOKINE PRODUCTION 14 563 0.0002308 0.002165
497 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 4 37 0.0002331 0.002169
498 GLIAL CELL MIGRATION 4 37 0.0002331 0.002169
499 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 4 37 0.0002331 0.002169
500 AXON EXTENSION 4 37 0.0002331 0.002169
501 REGULATION OF FAT CELL DIFFERENTIATION 6 106 0.0002406 0.00223
502 CARDIAC VENTRICLE DEVELOPMENT 6 106 0.0002406 0.00223
503 NEGATIVE REGULATION OF OSSIFICATION 5 69 0.0002567 0.00237
504 POSITIVE REGULATION OF AXONOGENESIS 5 69 0.0002567 0.00237
505 ACTIN MYOSIN FILAMENT SLIDING 4 38 0.0002589 0.002376
506 MUSCLE FILAMENT SLIDING 4 38 0.0002589 0.002376
507 MESENCHYME MORPHOGENESIS 4 38 0.0002589 0.002376
508 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 7 152 0.0002621 0.002401
509 REGULATION OF HEMOPOIESIS 10 314 0.0002749 0.002513
510 EXTRACELLULAR MATRIX ASSEMBLY 3 16 0.0002803 0.002542
511 DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 3 16 0.0002803 0.002542
512 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 3 16 0.0002803 0.002542
513 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 16 0.0002803 0.002542
514 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 7 154 0.0002839 0.00257
515 REGULATION OF AXON GUIDANCE 4 39 0.0002866 0.002585
516 EMBRYO IMPLANTATION 4 39 0.0002866 0.002585
517 REGULATION OF CELL CYCLE 19 949 0.0002965 0.002668
518 REGULATION OF PROTEIN LOCALIZATION 19 950 0.0003004 0.002698
519 REGULATION OF CELL CELL ADHESION 11 380 0.0003099 0.002778
520 POSITIVE REGULATION OF CELL MATRIX ADHESION 4 40 0.0003164 0.002831
521 REGULATION OF HOMEOSTATIC PROCESS 12 447 0.0003288 0.002936
522 NEGATIVE REGULATION OF CELL ACTIVATION 7 158 0.0003317 0.002957
523 NEGATIVE REGULATION OF ANOIKIS 3 17 0.0003383 0.00297
524 NEGATIVE REGULATION OF LIPID STORAGE 3 17 0.0003383 0.00297
525 CELLULAR RESPONSE TO KETONE 5 73 0.0003341 0.00297
526 MAMMARY GLAND ALVEOLUS DEVELOPMENT 3 17 0.0003383 0.00297
527 MAMMARY GLAND LOBULE DEVELOPMENT 3 17 0.0003383 0.00297
528 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 3 17 0.0003383 0.00297
529 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 3 17 0.0003383 0.00297
530 LYMPHOCYTE DIFFERENTIATION 8 209 0.0003373 0.00297
531 REGULATION OF LIPID STORAGE 4 41 0.0003484 0.003053
532 ACTIN FILAMENT BASED PROCESS 12 450 0.0003492 0.003054
533 ACTIN MEDIATED CELL CONTRACTION 5 74 0.000356 0.003108
534 RESPONSE TO BIOTIC STIMULUS 18 886 0.0003621 0.003155
535 INTERSPECIES INTERACTION BETWEEN ORGANISMS 15 662 0.0003719 0.003229
536 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 15 662 0.0003719 0.003229
537 RESPONSE TO CALCIUM ION 6 115 0.0003736 0.003237
538 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 5 75 0.0003789 0.003277
539 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 4 42 0.0003827 0.003299
540 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 8 213 0.0003829 0.003299
541 POSITIVE REGULATION OF RESPONSE TO WOUNDING 7 162 0.0003858 0.003319
542 PROTEIN COMPLEX BIOGENESIS 21 1132 0.0003916 0.003356
543 PROTEIN COMPLEX ASSEMBLY 21 1132 0.0003916 0.003356
544 POSITIVE REGULATION OF HEMOPOIESIS 7 163 0.0004004 0.003425
545 RESPONSE TO BACTERIUM 13 528 0.0004252 0.00363
546 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 6 118 0.0004288 0.003654
547 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 5 78 0.0004544 0.003866
548 BODY MORPHOGENESIS 4 44 0.0004582 0.003884
549 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 4 44 0.0004582 0.003884
550 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 3 19 0.0004763 0.004022
551 FIBRIL ORGANIZATION 3 19 0.0004763 0.004022
552 REGULATION OF CELLULAR COMPONENT SIZE 10 337 0.0004797 0.004043
553 BONE MORPHOGENESIS 5 79 0.000482 0.004055
554 REGULATION OF BLOOD PRESSURE 7 169 0.0004974 0.004178
555 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 4 45 0.0004997 0.004182
556 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 4 45 0.0004997 0.004182
557 VESICLE MEDIATED TRANSPORT 22 1239 0.0005125 0.004273
558 LOCALIZATION WITHIN MEMBRANE 6 122 0.0005121 0.004273
559 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 12 470 0.0005146 0.004283
560 REGULATION OF DEFENSE RESPONSE 16 759 0.0005228 0.004344
561 REGULATION OF ANATOMICAL STRUCTURE SIZE 12 472 0.0005342 0.004423
562 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 7 171 0.0005336 0.004423
563 METANEPHROS DEVELOPMENT 5 81 0.0005408 0.004469
564 REGULATION OF CHONDROCYTE DIFFERENTIATION 4 46 0.0005439 0.004487
565 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 7 172 0.0005525 0.00455
566 NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 3 20 0.000557 0.004555
567 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 3 20 0.000557 0.004555
568 NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 3 20 0.000557 0.004555
569 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 3 20 0.000557 0.004555
570 REGULATION OF PROTEIN MATURATION 5 82 0.0005721 0.00467
571 CELL FATE COMMITMENT 8 227 0.0005835 0.004755
572 PROTEOGLYCAN METABOLIC PROCESS 5 83 0.0006048 0.004911
573 RESPONSE TO FATTY ACID 5 83 0.0006048 0.004911
574 RESPONSE TO RADIATION 11 413 0.0006221 0.005043
575 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 48 0.0006403 0.005163
576 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 4 48 0.0006403 0.005163
577 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 48 0.0006403 0.005163
578 POSITIVE REGULATION OF KINASE ACTIVITY 12 482 0.0006424 0.005171
579 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 3 21 0.0006459 0.005173
580 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 3 21 0.0006459 0.005173
581 NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 3 21 0.0006459 0.005173
582 REGULATION OF SECRETION 15 699 0.0006533 0.005214
583 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 9 289 0.0006521 0.005214
584 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 10 351 0.0006572 0.005236
585 VIRAL LIFE CYCLE 9 290 0.0006684 0.005316
586 TUBE FORMATION 6 129 0.0006876 0.00546
587 CARDIAC SEPTUM MORPHOGENESIS 4 49 0.0006928 0.005492
588 REGULATION OF INFLAMMATORY RESPONSE 9 294 0.0007367 0.00583
589 POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 3 22 0.0007434 0.005873
590 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 6 131 0.0007454 0.005879
591 MYELOID CELL HOMEOSTASIS 5 88 0.0007897 0.006186
592 REGULATION OF COAGULATION 5 88 0.0007897 0.006186
593 OVULATION CYCLE PROCESS 5 88 0.0007897 0.006186
594 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 5 88 0.0007897 0.006186
595 POSITIVE REGULATION OF GROWTH 8 238 0.0007946 0.006214
596 NEGATIVE REGULATION OF CHEMOTAXIS 4 51 0.0008068 0.006299
597 MESENCHYMAL CELL DIFFERENTIATION 6 134 0.0008391 0.00654
598 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 12 498 0.0008535 0.006641
599 TISSUE REGENERATION 4 52 0.0008685 0.006747
600 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 6 135 0.0008723 0.006764
601 EPITHELIAL CELL DEVELOPMENT 7 186 0.0008769 0.006789
602 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 10 365 0.000886 0.006848
603 GLIAL CELL DIFFERENTIATION 6 136 0.0009064 0.006994
604 POSITIVE REGULATION OF CELL CELL ADHESION 8 243 0.000909 0.007002
605 REGULATION OF CYTOSKELETON ORGANIZATION 12 502 0.0009144 0.007033
606 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 7 188 0.0009334 0.007167
607 FOCAL ADHESION ASSEMBLY 3 24 0.0009654 0.007257
608 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 3 24 0.0009654 0.007257
609 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 3 24 0.0009654 0.007257
610 POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 3 24 0.0009654 0.007257
611 AXON REGENERATION 3 24 0.0009654 0.007257
612 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 3 24 0.0009654 0.007257
613 POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 3 24 0.0009654 0.007257
614 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 3 24 0.0009654 0.007257
615 REGULATION OF ODONTOGENESIS 3 24 0.0009654 0.007257
616 POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 3 24 0.0009654 0.007257
617 CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY 3 24 0.0009654 0.007257
618 REGULATION OF ANOIKIS 3 24 0.0009654 0.007257
619 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 3 24 0.0009654 0.007257
620 POSITIVE REGULATION OF SECRETION 10 370 0.000982 0.00737
621 STEM CELL DIFFERENTIATION 7 190 0.0009928 0.007439
622 CARDIAC MUSCLE TISSUE MORPHOGENESIS 4 54 0.001002 0.007494
623 POSITIVE REGULATION OF CELL CYCLE PROCESS 8 247 0.00101 0.007541
624 REGULATION OF CELL SHAPE 6 139 0.001015 0.00757
625 RESPONSE TO PROSTAGLANDIN E 3 25 0.00109 0.008067
626 DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION 3 25 0.00109 0.008067
627 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 25 0.00109 0.008067
628 CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 3 25 0.00109 0.008067
629 REGULATION OF PROTEIN COMPLEX ASSEMBLY 10 375 0.001087 0.008067
630 POSITIVE REGULATION OF CELL ACTIVATION 9 311 0.001094 0.008078
631 CANONICAL WNT SIGNALING PATHWAY 5 95 0.001116 0.008226
632 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 12 514 0.00112 0.008243
633 NEGATIVE REGULATION OF GENE EXPRESSION 24 1493 0.001145 0.008417
634 DEFENSE RESPONSE 21 1231 0.001149 0.008433
635 CARDIOCYTE DIFFERENTIATION 5 96 0.001169 0.008567
636 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 3 26 0.001225 0.008908
637 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 3 26 0.001225 0.008908
638 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 7 197 0.001224 0.008908
639 NEGATIVE REGULATION OF LIPID TRANSPORT 3 26 0.001225 0.008908
640 REGULATION OF P38MAPK CASCADE 3 26 0.001225 0.008908
641 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 3 27 0.00137 0.009915
642 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 3 27 0.00137 0.009915
643 NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 3 27 0.00137 0.009915
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 23 76 2.489e-30 2.312e-27
2 RECEPTOR BINDING 59 1476 5.96e-26 2.768e-23
3 GLYCOSAMINOGLYCAN BINDING 27 205 6.084e-25 1.884e-22
4 EXTRACELLULAR MATRIX BINDING 17 51 1.703e-23 3.956e-21
5 INTEGRIN BINDING 20 105 5.006e-22 7.751e-20
6 CELL ADHESION MOLECULE BINDING 24 186 4.952e-22 7.751e-20
7 HEPARIN BINDING 22 157 4.533e-21 6.015e-19
8 COLLAGEN BINDING 16 65 9.079e-20 1.054e-17
9 SULFUR COMPOUND BINDING 24 234 1.228e-19 1.267e-17
10 PROTEIN COMPLEX BINDING 39 935 1.945e-17 1.807e-15
11 STRUCTURAL MOLECULE ACTIVITY 31 732 4.244e-14 3.584e-12
12 CALCIUM ION BINDING 30 697 7.601e-14 5.884e-12
13 MACROMOLECULAR COMPLEX BINDING 41 1399 4.297e-13 3.071e-11
14 FIBRONECTIN BINDING 9 28 8.121e-13 5.389e-11
15 GROWTH FACTOR BINDING 14 123 1.581e-12 9.793e-11
16 CYTOKINE ACTIVITY 16 219 3.631e-11 2.108e-09
17 PLATELET DERIVED GROWTH FACTOR BINDING 6 11 1.239e-10 6.768e-09
18 CYTOKINE RECEPTOR BINDING 15 271 7.047e-09 3.637e-07
19 GLYCOPROTEIN BINDING 10 101 1.056e-08 5.162e-07
20 PROTEASE BINDING 10 104 1.405e-08 6.524e-07
21 CHEMOATTRACTANT ACTIVITY 6 27 7.119e-08 3.149e-06
22 GROWTH FACTOR ACTIVITY 11 160 8.717e-08 3.681e-06
23 VIRUS RECEPTOR ACTIVITY 8 70 1.056e-07 4.265e-06
24 SMAD BINDING 8 72 1.32e-07 5.111e-06
25 LAMININ BINDING 6 30 1.399e-07 5.2e-06
26 GROWTH FACTOR RECEPTOR BINDING 9 129 1.19e-06 4.25e-05
27 PEPTIDASE REGULATOR ACTIVITY 11 214 1.599e-06 5.384e-05
28 INSULIN LIKE GROWTH FACTOR BINDING 5 25 1.623e-06 5.384e-05
29 PROTEOGLYCAN BINDING 5 30 4.211e-06 0.0001349
30 ACTIN BINDING 14 393 4.648e-06 0.0001439
31 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 4 15 5.545e-06 0.0001662
32 CYTOKINE BINDING 7 92 1.07e-05 0.0003108
33 ENZYME REGULATOR ACTIVITY 22 959 1.242e-05 0.0003496
34 MOLECULAR FUNCTION REGULATOR 26 1353 4.149e-05 0.001134
35 ENZYME INHIBITOR ACTIVITY 12 378 6.946e-05 0.001844
36 WNT PROTEIN BINDING 4 31 0.0001154 0.002977
37 SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY 6 95 0.000132 0.003315
38 PROTEIN DOMAIN SPECIFIC BINDING 15 624 0.0001984 0.004851
39 PEPTIDASE ACTIVATOR ACTIVITY 4 38 0.0002589 0.006012
40 CORECEPTOR ACTIVITY 4 38 0.0002589 0.006012
41 TRANSFORMING GROWTH FACTOR BETA BINDING 3 16 0.0002803 0.006199
42 RECEPTOR AGONIST ACTIVITY 3 16 0.0002803 0.006199
43 METALLOENDOPEPTIDASE ACTIVITY 6 113 0.00034 0.007346
44 STRUCTURAL CONSTITUENT OF MUSCLE 4 41 0.0003484 0.007356
45 CYTOSKELETAL PROTEIN BINDING 17 819 0.000416 0.008587
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX 67 426 7.653e-69 4.47e-66
2 PROTEINACEOUS EXTRACELLULAR MATRIX 62 356 3.174e-66 9.267e-64
3 EXTRACELLULAR MATRIX COMPONENT 36 125 2.246e-46 4.373e-44
4 EXTRACELLULAR SPACE 72 1376 3.205e-40 4.679e-38
5 BASEMENT MEMBRANE 22 93 2.192e-26 2.56e-24
6 COMPLEX OF COLLAGEN TRIMERS 13 23 4.979e-22 4.846e-20
7 COLLAGEN TRIMER 18 88 1.599e-20 1.334e-18
8 CELL SUBSTRATE JUNCTION 28 398 2.266e-18 1.654e-16
9 CELL SURFACE 35 757 4.976e-17 3.061e-15
10 ANCHORING JUNCTION 29 489 5.242e-17 3.061e-15
11 ENDOPLASMIC RETICULUM LUMEN 20 201 2.927e-16 1.554e-14
12 BANDED COLLAGEN FIBRIL 8 12 8.286e-15 4.032e-13
13 INTRACELLULAR VESICLE 38 1259 1.558e-12 7.001e-11
14 PLATELET ALPHA GRANULE 11 75 2.504e-11 1.045e-09
15 SECRETORY GRANULE 18 352 7.228e-10 2.814e-08
16 CELL JUNCTION 31 1151 3.989e-09 1.456e-07
17 GOLGI LUMEN 10 94 5.219e-09 1.793e-07
18 SECRETORY VESICLE 19 461 8.335e-09 2.704e-07
19 EXTERNAL SIDE OF PLASMA MEMBRANE 14 238 1.059e-08 3.256e-07
20 PLATELET ALPHA GRANULE LUMEN 8 55 1.511e-08 4.413e-07
21 VESICLE LUMEN 10 106 1.69e-08 4.7e-07
22 SECRETORY GRANULE LUMEN 9 85 3.249e-08 8.626e-07
23 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 6 30 1.399e-07 3.553e-06
24 ENDOPLASMIC RETICULUM PART 28 1163 2.616e-07 6.365e-06
25 SIDE OF MEMBRANE 16 428 4.987e-07 1.12e-05
26 FILAMENTOUS ACTIN 5 20 4.895e-07 1.12e-05
27 LYSOSOMAL LUMEN 8 88 6.346e-07 1.373e-05
28 SARCOLEMMA 9 125 9.127e-07 1.904e-05
29 PLASMA MEMBRANE PROTEIN COMPLEX 17 510 1.058e-06 2.13e-05
30 CELL LEADING EDGE 14 350 1.207e-06 2.35e-05
31 GOLGI APPARATUS 30 1445 2.071e-06 3.902e-05
32 VACUOLAR LUMEN 8 115 4.843e-06 8.839e-05
33 ENDOPLASMIC RETICULUM 31 1631 8.324e-06 0.0001473
34 CYTOPLASMIC VESICLE PART 17 601 9.46e-06 0.0001625
35 CONTRACTILE FIBER 10 211 9.867e-06 0.0001646
36 LAMELLIPODIUM 9 172 1.262e-05 0.0002048
37 LAMELLIPODIUM MEMBRANE 4 19 1.535e-05 0.0002422
38 RECEPTOR COMPLEX 12 327 1.699e-05 0.0002611
39 ACTIN CYTOSKELETON 14 444 1.84e-05 0.0002755
40 BASAL LAMINA 4 21 2.339e-05 0.0003278
41 GLYCOPROTEIN COMPLEX 4 21 2.339e-05 0.0003278
42 ACTIN FILAMENT 6 70 2.357e-05 0.0003278
43 GOLGI APPARATUS PART 20 893 4.465e-05 0.0006064
44 RUFFLE MEMBRANE 6 80 5.05e-05 0.0006703
45 INTRINSIC COMPONENT OF PLASMA MEMBRANE 29 1649 7.063e-05 0.0009167
46 PLASMA MEMBRANE RECEPTOR COMPLEX 8 175 0.0001003 0.001274
47 ACTIN FILAMENT BUNDLE 5 57 0.0001035 0.001286
48 INVADOPODIUM 3 12 0.0001128 0.001372
49 LEADING EDGE MEMBRANE 7 134 0.0001203 0.001434
50 MEMBRANE REGION 22 1134 0.0001505 0.001758
51 ACTOMYOSIN 5 62 0.0001548 0.001769
52 CELL CORTEX 9 238 0.0001575 0.001769
53 INTERSTITIAL MATRIX 3 14 0.0001844 0.001994
54 FIBRIL 3 14 0.0001844 0.001994
55 ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT 6 105 0.0002285 0.002427
56 ANCHORED COMPONENT OF MEMBRANE 7 152 0.0002621 0.002734
57 CELL PROJECTION 29 1786 0.0002799 0.002868
58 RUFFLE 7 156 0.000307 0.003092
59 LYTIC VACUOLE 13 526 0.0004103 0.004061
60 CORTICAL CYTOSKELETON 5 81 0.0005408 0.005263
61 CYTOPLASMIC REGION 9 287 0.0006206 0.005942
62 PLASMA MEMBRANE REGION 18 929 0.0006322 0.005955
63 CELL PROJECTION PART 18 946 0.0007793 0.007224
64 MYOFILAMENT 3 24 0.0009654 0.008809
65 CELL CELL ADHERENS JUNCTION 4 54 0.001002 0.008864
66 NEUROMUSCULAR JUNCTION 4 54 0.001002 0.008864

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04512_ECM.receptor_interaction 26 85 2.444e-34 4.399e-32
2 hsa04510_Focal_adhesion 31 200 7.895e-31 7.106e-29
3 hsa04151_PI3K_AKT_signaling_pathway 25 351 1.319e-16 7.912e-15
4 hsa04974_Protein_digestion_and_absorption 12 81 2.671e-12 1.202e-10
5 hsa04810_Regulation_of_actin_cytoskeleton 12 214 2.081e-07 7.493e-06
6 hsa04640_Hematopoietic_cell_lineage 7 88 7.972e-06 0.0002392
7 hsa04390_Hippo_signaling_pathway 8 154 4.078e-05 0.001006
8 hsa04145_Phagosome 8 156 4.47e-05 0.001006
9 hsa04350_TGF.beta_signaling_pathway 6 85 7.106e-05 0.001421
10 hsa04514_Cell_adhesion_molecules_.CAMs. 7 136 0.000132 0.002376
11 hsa04115_p53_signaling_pathway 5 69 0.0002567 0.0042
12 hsa04010_MAPK_signaling_pathway 9 268 0.0003787 0.005681
13 hsa04672_Intestinal_immune_network_for_IgA_production 4 49 0.0006928 0.009593
14 hsa04670_Leukocyte_transendothelial_migration 5 117 0.002794 0.03592
15 hsa04310_Wnt_signaling_pathway 5 151 0.008178 0.09813
16 hsa04270_Vascular_smooth_muscle_contraction 4 116 0.01535 0.1727
17 hsa04610_Complement_and_coagulation_cascades 3 69 0.01911 0.2024
18 hsa04380_Osteoclast_differentiation 4 128 0.02123 0.2115
19 hsa04360_Axon_guidance 4 130 0.02232 0.2115
20 hsa04260_Cardiac_muscle_contraction 3 77 0.02546 0.2291
21 hsa04014_Ras_signaling_pathway 5 236 0.04525 0.3879
22 hsa04912_GnRH_signaling_pathway 3 101 0.05039 0.404
23 hsa04620_Toll.like_receptor_signaling_pathway 3 102 0.05162 0.404
24 hsa00480_Glutathione_metabolism 2 50 0.06338 0.4754
25 hsa04150_mTOR_signaling_pathway 2 52 0.0679 0.4888
26 hsa04340_Hedgehog_signaling_pathway 2 56 0.07722 0.5346
27 hsa04621_NOD.like_receptor_signaling_pathway 2 59 0.08446 0.5631
28 hsa04110_Cell_cycle 3 128 0.0883 0.5676
29 hsa04012_ErbB_signaling_pathway 2 87 0.1598 0.959
30 hsa04540_Gap_junction 2 90 0.1685 0.9785
31 hsa04916_Melanogenesis 2 101 0.201 1
32 hsa04722_Neurotrophin_signaling_pathway 2 127 0.2796 1
33 hsa04630_Jak.STAT_signaling_pathway 2 155 0.3636 1
34 hsa04020_Calcium_signaling_pathway 2 177 0.4271 1
35 hsa04062_Chemokine_signaling_pathway 2 189 0.4603 1
36 hsa04144_Endocytosis 2 203 0.4976 1

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

MEG3

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-20a-5p;hsa-miR-330-3p;hsa-miR-335-5p;hsa-miR-3662;hsa-miR-577;hsa-miR-616-5p;hsa-miR-7-1-3p 11 TIMP3 Sponge network -1.645 0.00049 -1.706 0.00021 0.569
2

MEG3

 hsa-miR-107;hsa-miR-128-3p;hsa-miR-151a-3p;hsa-miR-15b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-222-5p;hsa-miR-330-3p;hsa-miR-3662;hsa-miR-429;hsa-miR-577;hsa-miR-616-5p 12 GREM1 Sponge network -1.645 0.00049 -0.7 0.31248 0.56
3

PCA3

 hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-107;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-3662;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-590-5p 12 ABI3BP Sponge network -2.778 8.0E-5 -3.776 0 0.551
4

MEG3

 hsa-miR-18a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-27b-5p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-3662;hsa-miR-429;hsa-miR-616-5p;hsa-miR-7-1-3p 12 FSTL1 Sponge network -1.645 0.00049 -0.228 0.50923 0.543
5

MEG3

 hsa-let-7d-5p;hsa-miR-151a-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-577;hsa-miR-616-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 17 THBS1 Sponge network -1.645 0.00049 -1.249 0.00266 0.524
6

MEG3

 hsa-let-7d-5p;hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-130b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-29b-1-5p;hsa-miR-331-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-339-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-577;hsa-miR-616-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 26 SGCD Sponge network -1.645 0.00049 -1.803 0.00073 0.521
7

MEG3

 hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-197-3p;hsa-miR-20a-5p;hsa-miR-320b;hsa-miR-429;hsa-miR-93-5p 13 CALD1 Sponge network -1.645 0.00049 -1.329 0.00086 0.517
8

MEG3

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-320b;hsa-miR-3662;hsa-miR-429;hsa-miR-7-1-3p 10 FERMT2 Sponge network -1.645 0.00049 -1.676 2.0E-5 0.503
9

MEG3

 hsa-miR-106b-5p;hsa-miR-1976;hsa-miR-200b-5p;hsa-miR-26b-3p;hsa-miR-29b-1-5p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-550a-3p;hsa-miR-616-5p;hsa-miR-7-1-3p 11 PRRX1 Sponge network -1.645 0.00049 1.075 0.04394 0.475
10

PCA3

 hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-1271-5p;hsa-miR-183-5p;hsa-miR-21-5p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-944;hsa-miR-96-5p 10 TPM1 Sponge network -2.778 8.0E-5 -1.202 0.00017 0.472
11

MEG3

 hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-429 10 MFAP5 Sponge network -1.645 0.00049 -3.318 0.00023 0.463
12

RFPL1S

 hsa-miR-107;hsa-miR-1266-5p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-375;hsa-miR-532-3p 11 DPYSL3 Sponge network -0.223 0.70704 -0.821 0.09933 0.458
13

RFPL1S

 hsa-miR-106b-5p;hsa-miR-126-5p;hsa-miR-144-3p;hsa-miR-148b-5p;hsa-miR-1976;hsa-miR-200b-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-320b;hsa-miR-338-3p;hsa-miR-550a-3p;hsa-miR-7-1-3p 13 PRRX1 Sponge network -0.223 0.70704 1.075 0.04394 0.449
14

RFPL1S

 hsa-miR-107;hsa-miR-144-5p;hsa-miR-200b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-320b;hsa-miR-429;hsa-miR-7-1-3p 10 FERMT2 Sponge network -0.223 0.70704 -1.676 2.0E-5 0.44
15

MEG3

 hsa-miR-141-3p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-33a-3p;hsa-miR-378a-5p;hsa-miR-429;hsa-miR-577;hsa-miR-7-1-3p;hsa-miR-96-5p 11 WIPF1 Sponge network -1.645 0.00049 0.012 0.97319 0.44
16

EMX2OS

 hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-16-2-3p;hsa-miR-188-5p;hsa-miR-200c-5p;hsa-miR-335-3p;hsa-miR-550a-3p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-625-5p 11 SLIT3 Sponge network -1.088 0.10042 -2.271 0 0.428
17

RFPL1S

 hsa-miR-106b-5p;hsa-miR-107;hsa-miR-144-5p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-148b-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-532-5p;hsa-miR-7-1-3p 17 SGCD Sponge network -0.223 0.70704 -1.803 0.00073 0.427
18

PCA3

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-23a-3p;hsa-miR-27a-3p;hsa-miR-296-5p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-944 18 TGFBR3 Sponge network -2.778 8.0E-5 -2.545 0 0.424
19

PCA3

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-200b-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3682-3p;hsa-miR-424-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p 17 MYLK Sponge network -2.778 8.0E-5 -1.782 0.00021 0.419
20

PCA3

 hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-330-3p;hsa-miR-335-5p;hsa-miR-3662;hsa-miR-3682-3p;hsa-miR-424-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p 28 FGF2 Sponge network -2.778 8.0E-5 -1.879 0.00013 0.416
21

MEG3

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-3662;hsa-miR-429;hsa-miR-577;hsa-miR-93-3p 19 FGF2 Sponge network -1.645 0.00049 -1.879 0.00013 0.415
22

RFPL1S

 hsa-miR-126-5p;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-23a-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-375;hsa-miR-429;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-625-5p 13 SPOCK1 Sponge network -0.223 0.70704 0.274 0.67632 0.412
23

RFPL1S

 hsa-miR-106b-5p;hsa-miR-144-3p;hsa-miR-148a-5p;hsa-miR-188-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-505-3p;hsa-miR-660-5p;hsa-miR-7-1-3p 11 TIMP3 Sponge network -0.223 0.70704 -1.706 0.00021 0.398
24

DGCR5

 hsa-let-7g-5p;hsa-miR-126-5p;hsa-miR-140-5p;hsa-miR-150-5p;hsa-miR-192-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-215-5p;hsa-miR-30d-3p;hsa-miR-326;hsa-miR-362-5p;hsa-miR-500a-3p;hsa-miR-532-3p;hsa-miR-577;hsa-miR-592 15 DST Sponge network 1.383 0.01835 -0.242 0.5214 0.394
25

PCA3

 hsa-miR-1271-5p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-200a-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-23a-3p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-96-5p 12 CXCL12 Sponge network -2.778 8.0E-5 -2.246 0 0.389
26

MEG3

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-197-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-3662;hsa-miR-532-3p;hsa-miR-616-5p 10 DPYSL3 Sponge network -1.645 0.00049 -0.821 0.09933 0.382
27

DGCR5

 hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-140-5p;hsa-miR-148a-5p;hsa-miR-2110;hsa-miR-30d-3p;hsa-miR-326;hsa-miR-375;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-625-5p 11 SPOCK1 Sponge network 1.383 0.01835 0.274 0.67632 0.38
28

MEG3

 hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-1976;hsa-miR-200c-5p;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-429;hsa-miR-550a-3p;hsa-miR-577;hsa-miR-616-5p;hsa-miR-96-5p 14 SLIT3 Sponge network -1.645 0.00049 -2.271 0 0.376
29 PLAC4 hsa-miR-1271-5p;hsa-miR-149-5p;hsa-miR-193b-3p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-324-5p;hsa-miR-331-3p;hsa-miR-34c-5p;hsa-miR-455-3p;hsa-miR-744-3p 11 QSOX1 Sponge network -0.563 0.27163 -1.183 0.00013 0.376
30

PCA3

 hsa-let-7d-5p;hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-25-3p;hsa-miR-32-3p;hsa-miR-331-5p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3682-3p;hsa-miR-424-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-93-5p 32 SGCD Sponge network -2.778 8.0E-5 -1.803 0.00073 0.375
31

MEG3

 hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-577 11 MYLK Sponge network -1.645 0.00049 -1.782 0.00021 0.371
32

EMX2OS

 hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-192-3p;hsa-miR-200b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-424-5p;hsa-miR-577;hsa-miR-589-3p 12 MYLK Sponge network -1.088 0.10042 -1.782 0.00021 0.365
33

PCA3

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-3662;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p 15 FERMT2 Sponge network -2.778 8.0E-5 -1.676 2.0E-5 0.362
34

EMX2OS

 hsa-miR-16-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-222-3p;hsa-miR-32-3p;hsa-miR-338-5p;hsa-miR-362-3p;hsa-miR-423-5p;hsa-miR-505-3p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-660-5p;hsa-miR-7-1-3p 13 TIMP3 Sponge network -1.088 0.10042 -1.706 0.00021 0.362
35

EMX2OS

 hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-3p;hsa-miR-215-5p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-424-5p;hsa-miR-503-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-92a-3p;hsa-miR-93-3p 22 FGF2 Sponge network -1.088 0.10042 -1.879 0.00013 0.362
36

RFPL1S

 hsa-miR-148a-5p;hsa-miR-18a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-320b;hsa-miR-429;hsa-miR-7-1-3p 10 FSTL1 Sponge network -0.223 0.70704 -0.228 0.50923 0.359
37

EMX2OS

 hsa-miR-107;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-338-5p;hsa-miR-34a-5p;hsa-miR-501-3p 12 CALD1 Sponge network -1.088 0.10042 -1.329 0.00086 0.355
38

EMX2OS

 hsa-miR-1266-5p;hsa-miR-141-3p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-378a-5p;hsa-miR-577;hsa-miR-7-1-3p 10 WIPF1 Sponge network -1.088 0.10042 0.012 0.97319 0.354
39

PCA3

 hsa-miR-106b-5p;hsa-miR-107;hsa-miR-10b-3p;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-197-3p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-3682-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 17 CALD1 Sponge network -2.778 8.0E-5 -1.329 0.00086 0.351
40

AGAP11

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-130b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-25-3p;hsa-miR-423-5p;hsa-miR-424-5p;hsa-miR-590-5p 15 NOTCH2 Sponge network -1.728 0.00016 -0.258 0.28775 0.35
41

PART1

 hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-17-3p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-215-5p;hsa-miR-326;hsa-miR-335-3p;hsa-miR-362-5p;hsa-miR-500a-3p;hsa-miR-532-3p;hsa-miR-550a-5p;hsa-miR-577;hsa-miR-592 16 DST Sponge network -2.298 0.00168 -0.242 0.5214 0.338
42

RFPL1S

 hsa-miR-107;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-215-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-335-5p;hsa-miR-429 12 FGF2 Sponge network -0.223 0.70704 -1.879 0.00013 0.314
43

EMX2OS

 hsa-let-7d-5p;hsa-miR-107;hsa-miR-130b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-424-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p 24 SGCD Sponge network -1.088 0.10042 -1.803 0.00073 0.308
44

PCA3

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-629-3p;hsa-miR-940 19 THBS1 Sponge network -2.778 8.0E-5 -1.249 0.00266 0.302
45

EMX2OS

 hsa-miR-107;hsa-miR-151a-3p;hsa-miR-15b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-222-5p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-3614-5p;hsa-miR-362-3p;hsa-miR-577 11 GREM1 Sponge network -1.088 0.10042 -0.7 0.31248 0.301
46

RFPL1S

 hsa-miR-107;hsa-miR-126-5p;hsa-miR-17-3p;hsa-miR-222-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-330-5p;hsa-miR-338-3p;hsa-miR-375;hsa-miR-502-3p;hsa-miR-532-5p 11 COL12A1 Sponge network -0.223 0.70704 1.255 0.00321 0.29
47

NEAT1

 hsa-miR-1271-5p;hsa-miR-149-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-324-5p;hsa-miR-331-3p;hsa-miR-345-5p;hsa-miR-34c-5p;hsa-miR-374b-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-629-3p;hsa-miR-671-5p;hsa-miR-744-3p;hsa-miR-93-3p;hsa-miR-93-5p 16 QSOX1 Sponge network -0.686 0.02293 -1.183 0.00013 0.289
48

PCA3

 hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-148b-5p;hsa-miR-16-2-3p;hsa-miR-188-5p;hsa-miR-200c-5p;hsa-miR-224-3p;hsa-miR-301a-3p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-3682-3p;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-940;hsa-miR-96-5p 20 SLIT3 Sponge network -2.778 8.0E-5 -2.271 0 0.289
49

FAM95B1

 hsa-miR-16-2-3p;hsa-miR-18a-3p;hsa-miR-193b-3p;hsa-miR-23a-3p;hsa-miR-27a-3p;hsa-miR-323b-3p;hsa-miR-424-5p;hsa-miR-455-5p;hsa-miR-484;hsa-miR-944 10 TGFBR3 Sponge network -1.726 0.00466 -2.545 0 0.287
50

PCA3

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-188-5p;hsa-miR-19b-1-5p;hsa-miR-25-3p;hsa-miR-32-3p;hsa-miR-576-5p;hsa-miR-590-3p 10 FBN1 Sponge network -2.778 8.0E-5 -0.772 0.11079 0.286
51

AGAP11

 hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-3662;hsa-miR-423-5p;hsa-miR-590-5p 12 TIMP3 Sponge network -1.728 0.00016 -1.706 0.00021 0.278
52

EMX2OS

 hsa-let-7d-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-577;hsa-miR-7-1-3p;hsa-miR-92a-3p 13 THBS1 Sponge network -1.088 0.10042 -1.249 0.00266 0.277
53

PCA3

 hsa-miR-107;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-197-3p;hsa-miR-25-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-3662;hsa-miR-589-5p;hsa-miR-590-3p;hsa-miR-616-5p 11 DPYSL3 Sponge network -2.778 8.0E-5 -0.821 0.09933 0.273
54

AGAP11

 hsa-miR-106b-5p;hsa-miR-140-5p;hsa-miR-17-3p;hsa-miR-18a-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-215-5p;hsa-miR-320b;hsa-miR-326;hsa-miR-335-3p;hsa-miR-362-5p;hsa-miR-500a-3p;hsa-miR-532-3p 13 DST Sponge network -1.728 0.00016 -0.242 0.5214 0.268
55

AGAP11

 hsa-let-7d-5p;hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-130b-5p;hsa-miR-140-5p;hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-25-3p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-335-3p;hsa-miR-3682-3p;hsa-miR-424-5p;hsa-miR-590-5p;hsa-miR-93-5p 25 SGCD Sponge network -1.728 0.00016 -1.803 0.00073 0.263
56

PCA3

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-10b-3p;hsa-miR-128-3p;hsa-miR-15b-3p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-222-5p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-3662;hsa-miR-576-5p;hsa-miR-616-5p 15 GREM1 Sponge network -2.778 8.0E-5 -0.7 0.31248 0.257

Quest ID: 57dfc0d91f34aa67cd1a4a68da7a0fe6